Storia della carriera di Ami Bavishi
Precedenti posizioni note di Ami Bavishi
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| RALLYBIO CORPORATION | Contatto Relazioni con gli Investitori | 18/01/2022 | 01/04/2024 |
| Public Communications Contact | 18/01/2022 | 01/04/2024 | |
| AERIE PHARMACEUTICALS, INC. | Contatto Relazioni con gli Investitori | 02/01/2019 | - |
Formazione di Ami Bavishi
| Duquesne University of The Holy Spirit | Undergraduate Degree |
| George Washington University | Graduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
Posizioni
| Investor Relations Contact | 2 |
| Undergraduate Degree | 1 |
| Graduate Degree | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| RALLYBIO CORPORATION | Health Technology |
| Aziende private | 1 |
|---|---|
Aerie Pharmaceuticals, Inc.
 Aerie Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on January 1, 2005 and is headquartered in Durham, NCForth Worth, TX. | Health Technology |
- Borsa valori
- Insiders
- Ami Bavishi
- Esperienza